February 2026

Cardiovascular disease remains the leading cause of death worldwide, with atherosclerosis and elevated lipids at its core. For decades, statins have been the gold-standard therapy for lowering LDL cholesterol and stabilizing atherosclerotic plaque. But what if a naturally derived enzyme could offer comparable benefits and even outperform statins in certain aspects of plaque regression? This […]

For years, testosterone therapy (TRT) lived under a cloud of concern: does TRT increase the risk of heart attack, stroke, or cardiovascular death? The TRAVERSE trial was designed specifically to answer that question in the population that matters most—men who already have, or are at high risk for, cardiovascular disease. What Traverse Studied (The Design,